Name | Ro 24-0238 |
---|---|
Synonyms |
(R)-(2E,4E)-5-(4-methoxyphenyl)-N-[1-methyl-4-(3-pyridinyl)butyl]-2,4-decadienamide
[R-(E,E)]-5-(4-methoxyphenyl)-N-[1-methyl-4-(3-pyridinyl)butyl]-2.4-decadienamide (2E,4E)-5-(4-Methoxy-phenyl)-deca-2,4-dienoic acid ((R)-1-methyl-4-pyridin-3-yl-butyl)-amide <R-(E,E)>-5-(4-methoxyphenyl)-N-<1-methyl-4-(3-pyridinyl)butyl>-2,4-decadienamide (R-(E,E))-5-(4-methoxyphenyl)-N-[1-methyl-4-(3-pyridinyl)butyl]-2,4-decadienamide Ro-24-0238 |
Description | Ro-24-0238 is an antagonist of platelet activating factor (PAF) and inhibitor of thromboxane synthesis, used for lessening the inflammation and damage resulting from a local release of PAF. |
---|---|
Related Catalog | |
In Vivo | Pretreatment with 3 mg/kg Ro 24-0238 and 3 mg/kg WEB 2086 decreases the accumulation of neutrophils within the mucosa in rats[1]. |
References |
Molecular Formula | C27H36N2O2 |
---|---|
Molecular Weight | 420.58700 |
Exact Mass | 420.27800 |
PSA | 51.22000 |
LogP | 6.52860 |
Storage condition | 2-8℃ |